CTA Assessment of Coronary Atherosclerotic Plaque Evolution after BVS Implantation – a Follow-up Study

1. Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv. 2013;6:999-1009.10.1016/j.jcin.2013.05.017Search in Google Scholar

2. Maeng M, Tilsted HH, Jensen LO, et al. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORTOUT III study): a multicentre, open-label, randomised superiority trial. Lancet. 2014;383:2047-2056.10.1016/S0140-6736(14)60405-0Search in Google Scholar

3. Stone GW, Gao R, Kimura T, et al. 1-Year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. Lancet. 2016;387:1277-1289.10.1016/S0140-6736(15)01039-9Search in Google Scholar

4. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157-1166.10.1161/01.CIR.78.5.1157Search in Google Scholar

5. Benedek T, Bucur O, Pașcanu I, Benedek I. Analysis of coronary plaque morphology by 64 multislice computed tomography coronary angiography and calcium scoring in patients with type 2 diabetes mellitus. Acta Endocrinologica. 2011;7:59-68.10.4183/aeb.2011.59Search in Google Scholar

6. Benedek I, Chitu M, Kovacs I, Bajka B, Benedek T. Incremental Value of preprocedural Coronary Computed Tomographic Angiography to classical Coronary Angiography for prediction of PCI complexity in left main stenosis. World Journal of Cardiovascular Disease. 2013;9:573-580.10.4236/wjcd.2013.39090Search in Google Scholar

7. Benedek T, Jako B, Benedek I. Plaque quantification by coronary CT and intravascular ultrasound identifies a low CT density core as a marker of plaque instability in acute coronary syndromes. Int Heart J. 2014:55:22-28.10.1536/ihj.13-21324463925Search in Google Scholar

8. Benedek T, Gyongyosi M, Benedek I. Multislice computed tomographic coronary angiography for quantitative assessment of culprit lesions in acute coronary syndromes. Can J Cardiol. 2013;29:364-371.10.1016/j.cjca.2012.11.00423333164Search in Google Scholar

9. Gogas BD, Serruys PW, Diletti R, et al. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimuseluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. JACC Cardiovasc Interv. 2012;5:656-665.10.1016/j.jcin.2012.02.01722721662Search in Google Scholar

10. Verheye S, Martinet W, Kockx MM, et al. Selective clearance of macrophages in atherosclerotic plaques by autophagy. J Am Coll Cardiol. 2007;49:706-715.10.1016/j.jacc.2006.09.04717291937Search in Google Scholar

11. Ferent IF, Mester A, Hlinomaz O, et al. Intracoronary Imaging for Assessment of Vascular Healing and Stent Follow-up in Bioresorbable Vascular Scaffolds. Current Medical Imaging Reviews. 2018. [E-pub ahead of print.] doi: 10.2174/1573405614666180604093621.10.2174/157340561466618060409362132003312Open DOISearch in Google Scholar

12. Fajadet J, Haude M, Joner M, et al. Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016. EuroIntervention. 2016;12:828-833.10.4244/EIJV12I7A13727639734Search in Google Scholar

13. Capodanno D, Gori T, Nef H, et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2015;10:1144-1153.10.4244/EIJY14M07_1125042421Search in Google Scholar

14. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation. 2011;123:779-797.10.1161/CIRCULATIONAHA.110.971606Search in Google Scholar

15. Ormiston JA, De Vroey F, Serruys PW, Webster MW. Bioresorbable polymeric vascular scaffolds: a cautionary tale. Circ Cardiovasc Interv. 2011;4:535-538.10.1161/CIRCINTERVENTIONS.111.96371022010192Search in Google Scholar

16. Bourantas CV, Garcia-Garcia HM, Diletti R, Muramatsu T, Serruys PW. Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras? Am Heart J. 2013;165:869-881.10.1016/j.ahj.2013.02.015Search in Google Scholar

17. Brugaletta S, Heo JH, Garcia-Garcia HM, et al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J. 2012;33:1325-1333.10.1093/eurheartj/ehr466Search in Google Scholar

18. Brugaletta S, Radu MD, Garcia-Garcia HM, et al. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis. 2012;221:106-112.10.1016/j.atherosclerosis.2011.12.008Search in Google Scholar

19. Gomez-Lara J, Brugaletta S, Farooq V, et al. Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC Cardiovasc Interv. 2011;4:789-799.10.1016/j.jcin.2011.04.00921777888Search in Google Scholar

20. Lane JP, Perkins LE, Sheehy AJ, et al. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries. JACC Cardiovasc Interv. 2014;7:688-695.10.1016/j.jcin.2013.11.02424835327Search in Google Scholar

21. Serruys PW, Onuma Y. Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist’s jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS? EuroIntervention. 2017;12:2047-2056.10.4244/EIJY17M02_01Search in Google Scholar

22. James SK, Stenestrand U, Lindback J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009;360:1933-1945.10.1056/NEJMoa080990219420363Search in Google Scholar

23. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009-1019.10.1056/NEJMoa06772217296822Search in Google Scholar

24. Serruys PW, Daemen J. The SCAAR registry or the Swedish yo-yo. EuroIntervention. 2007;3:297-300.10.4244/EIJV3I3A5419737707Search in Google Scholar